$PANW spent $1 billion buying back its own stock across two trading days in February 2026, zeroing out the remaining balance under its existing repurchase authorization. The board responded on March 10 by approving another $1 billion. The 8-K filed March 11 captures both events together, and the pairing tells a specific story about how the company manages capital return.

The February Execution Was Concentrated and Deliberate

The repurchase happened on February 20 and February 24, 2026. $PANW bought approximately 6.8 million shares at an average price of $147.69 per share, deploying the entire $1 billion that remained available under the prior authorization. Concentrating that volume across two days rather than spreading it over weeks is a choice. It signals the company saw a price level it wanted to act on, not a passive drip program running on autopilot.

The February 24 date is relevant context. That date coincides with the 52-week low in $PANW's price history, per cached price data as of May 20, 2026. The stock has since moved sharply higher, up roughly 45% over the 30 days ending May 20 and up more than 63% over the trailing 90 days. The buyback was executed near the bottom of that range.

Seven Renewals and a Program That Never Really Stops

The original repurchase authorization dates to February 2019. It has been extended in December 2020, August 2021, August 2022, November 2023, August 2024, November 2025, and now March 2026. That is seven renewals across seven years. The pattern makes clear this is a standing capital return mechanism, not a one-time event.

As of March 6, 2026, $PANW had approximately 811 million shares outstanding. The new $1 billion authorization represents roughly 0.5% of the outstanding share count at the February average price, a modest but consistent reduction in the float. The authorization expires December 31, 2026, and the filing states it may be suspended or discontinued at any time without prior notice.

Filing Risk Reflects Disclosure Density, Not Distress

$PANW's Filing Risk Score sits at 100, the ceiling of the range, driven by the density of recent SEC filings rather than any financial distress signal. The elevated disclosure cadence reflects a company generating frequent material events, of which this buyback authorization is one. Event Momentum is also at the ceiling, consistent with the volume of recent filing activity.

The Insider Activity Signal at 52 sits just above the neutral baseline, indicating activity that is present but not clustered in a way that demands separate explanation. The BTC Exposure Score of 5 reflects $PANW's position as a cybersecurity platform company with no meaningful direct Bitcoin exposure on its balance sheet or in its revenue structure.

The Price Recovery Changes the Repurchase Math

The February purchases were made at $147.69 per share. The stock closed May 20 at $246.66, up roughly 67% from that execution price. That gap matters for how the remaining $1 billion authorization gets deployed. Repurchasing at current levels costs significantly more per share than the February tranche did, which means the board's appetite to execute aggressively at higher prices is the real variable to watch.

The filing states the new authorization will be funded from available working capital. That is the disclosed use of the repurchase capacity. No specific deployment timeline or minimum purchase commitment is stated, which is standard for this type of authorization.

$PANW's risk-factor profile has also shifted recently, with 8 added, 8 removed, and 8 materially changed Item 1A candidates identified in the comparison of the August 2025 10-K against the September 2024 10-K. That level of risk-factor turnover in a single annual filing cycle is worth tracking alongside the capital return activity, since the two together describe a company actively managing both its disclosure posture and its share count.

The next concrete read on execution pace will come from the next quarterly filing, which will show how much of the new $1 billion authorization $PANW used between March 10 and quarter end, and at what average price.

Research only. Not investment advice.